🔎 Trials Near Me

Home › Cancer (all types) › Michigan › Warren

Cancer (all types) clinical trials in Warren, MI

5 studies for Cancer (all types) are looking for participants at sites in and around Warren (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

RecruitingPhase 3
  • Henry Ford Health Warren Hospital, Warren
  • Henry Ford Madison Heights Hospital - Breast, Warren
  • Henry Ford Warren Hospital - GLCMS, Warren
  • and 3 more
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06580314

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

RecruitingPhase 3
  • Comprehensive Urology, Royal Oak · 7 mi away
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07566156

Suprachoroidal Administration in Subjects With Metastases to the Choroid

RecruitingPhase 2
  • Associated Retinal Consultants (ARC) PC, Royal Oak · 7 mi away
Ages 18 and older · All sexes · Updated Oct 8, 2026 · NCT06643884

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

RecruitingPhase 2
  • Henry Ford Health Warren Hospital, Warren
Ages 12 and older · All sexes · Updated Sep 22, 2026 · NCT02693535

Project: Every Child for Younger Patients With Cancer

RecruitingObservational study
  • Corewell Health Children's, Royal Oak · 7 mi away
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244

About Cancer (all types)

If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.

More about Cancer (all types) on MedlinePlus

Cancer (all types) trials in other cities

Other studies in Warren

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.